RGF
CORT icon

Retirement Guys Formula’s Corcept Therapeutics CORT Stock Holding History

Retirement Guys Formula’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,946
Closed -$245K – 159
2025
Q3 		$245K Buy
2,946
+47
+2% +$3.4K 0.09% 141
2025
Q2 		$213K Sell
2,899
-248
-8% -$18K 0.08% 133
2025
Q1 		$359K Sell
3,147
-1,297
-29% -$78.9K 0.18% 105
2024
Q4 		$224K Sell
4,444
-634
-12% -$33.2K 0.11% 122
2024
Q3 		$235K Buy
+5,078
New +$180K 0.11% 114

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Retirement Guys Formula's CORT Position: Q4 2025 in Review

Retirement Guys Formula sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 2,946 shares — an estimated $245K sold.

Retirement Guys Formula first reported a position in CORT in Q3 2024 and held it in 5 quarters. The position peaked at $359K in Q1 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Retirement Guys Formula reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Retirement Guys Formula sold 2,946 Corcept Therapeutics shares in Q4 2025, an estimated $245K.
  • Retirement Guys Formula first reported a position in Corcept Therapeutics in Q3 2024 and held it in 5 quarters.
  • Retirement Guys Formula's Corcept Therapeutics position peaked at $359K in Q1 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Retirement Guys Formula's 13F filing for Q4 2025, filed 23 Jan 2026.